SCHEDULE: Artisan Partners Reports 7.9% Stake in Veracyte

Artisan Partners Asset Management Inc. and its affiliates disclosed a 7.9% beneficial ownership stake in Veracyte, Inc. common stock as of December 31, 2025.

Summary

• Artisan Partners Asset Management Inc., along with its affiliated entities Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership, collectively reported beneficial ownership of 6,263,041 shares of Veracyte, Inc. common stock.
• This aggregate amount represents 7.9% of Veracyte, Inc.'s outstanding common stock, based on 79,049,173 shares outstanding as of October 31, 2025.
• The reporting persons hold shared voting power over 5,457,186 shares and shared dispositive power over all 6,263,041 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Veracyte, Inc.
• The shares are held on behalf of discretionary clients of Artisan Partners Limited Partnership, with no single client having an economic interest exceeding 5% of the class.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant and ongoing institutional stake by a reputable asset manager like Artisan Partners typically reflects confidence in the issuer's value and future prospects.

Positives

• The disclosure of a significant 7.9% stake by a prominent institutional investor like Artisan Partners indicates strong institutional confidence in Veracyte, Inc.'s long-term prospects and business model.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that a substantial stake by a major asset manager like Artisan Partners in a diagnostics and life sciences company such as Veracyte, Inc. often signals a belief in the company's innovation, market position, and growth potential within the competitive healthcare technology sector. This type of institutional investment can be a positive indicator for other investors, suggesting a thorough due diligence process has been undertaken.

Stakeholder Impact

• Shareholders may view this significant institutional ownership as a positive signal, potentially increasing investor confidence and attracting further investment.
• The presence of a large institutional investor can sometimes lead to increased scrutiny of corporate governance and strategic decisions, which could benefit all stakeholders.

Key Dates

Recommendation

The disclosure of a significant 7.9% beneficial ownership by Artisan Partners, a well-regarded institutional investor, indicates continued confidence in Veracyte, Inc. While not a new investment, the maintenance of such a substantial stake suggests that Artisan Partners sees ongoing value. This institutional backing provides a strong signal to the market, making 'hold' a prudent recommendation for existing investors, and potentially a 'buy' for those looking for companies with strong institutional support.

Keywords

Veracyte, Artisan Partners, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Asset Management, Biotechnology, Diagnostics